At Univercells Technologies, we deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining. Our innovative solutions, including the scale-X™ bioreactor and NevoLine™ Upstream platform, are designed to provide cost-effective and scalable viral production. We are committed to supporting our clients in the fast-growing gene therapy market with high levels of process control and production capabilities that meet FDA and EMA standards.